ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a life sciences-focused special purpose acquisition company sponsored by ARYA Sciences Holdings IV, an entity affiliated with Perceptive Advisors, a healthcare-oriented investment firm. The vehicle completed its initial public offering in 2021 and targets opportunities in the biopharmaceutical and life sciences sector. In February 2024 the company filed an amended Form 8-K with the Securities and Exchange Commission, accession number 0001140361-24-007980, reflecting an update to a previously disclosed material event. ARYD is one of several SPAC vehicles in the ARYA Sciences series, each designed to source and consummate a business combination within the healthcare and biotechnology space. Visit SpacDesk and sign up for full access to ARYD's filing history, trust account data, extension timeline, and comparable transaction analytics.